Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56]

Abstract
No abstract available
Funding Information
  • RGC General Research (17120215)